Grey Matter Neurosciences
Developing non-invasive ultrasound technology to treat age-related brain diseases like Alzheimer's.
About
Grey Matter Neurosciences is a Toronto-based medical technology company focused on developing revolutionary, non-invasive neuromodulation products. Their core technology utilizes transcranial focused ultrasound to treat age-related brain diseases, aiming to empower seniors to manage cognitive and mood disorders outside of clinical settings. Teams look it up for Neurotechnology, Medical Devices, HealthTech.
Frequently asked
What does Grey Matter Neurosciences do?
Grey Matter Neurosciences is a Neurotechnology company that offers Hardware. Teams look it up for Medical Devices, HealthTech, Biotechnology. It is based in Toronto, Canada and was founded in 2021. Public records show $14M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Grey Matter Neurosciences raised?
Grey Matter Neurosciences has raised a total of $14M in funding. The most recent round on record is Seed.
Where is Grey Matter Neurosciences headquartered?
Grey Matter Neurosciences is headquartered in Toronto, Canada.
When was Grey Matter Neurosciences founded?
Grey Matter Neurosciences was founded in 2021.
What industry does Grey Matter Neurosciences operate in?
Grey Matter Neurosciences operates in Neurotechnology, Medical Devices, HealthTech, Biotechnology.